Fc Receptor Targeting Reduces Bone Disease in a Pre-Clinical Model of Multiple Myeloma

被引：0
|
作者：
Williams, Mark T. [1 ]
Thuemmler, Katya [1 ]
Kitson, Susan [1 ]
Soutar, Richard [2 ]
Goodyear, Carl S. [1 ]
机构：
[1] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland
[2] Gartnavel Hosp, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A role for B cell suppression in a pre-clinical model of multiple myeloma
    Fowler, Jessica
    Mundy, Greg
    Edwards, Claire
    CANCER TREATMENT REVIEWS, 2008, 34 : S53 - S53
  • [2] Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma
    de Brito, Luis R.
    Batey, Mike A.
    Zhao, Yan
    Squires, Matt S.
    Maitland, Helen
    Leung, Hing Y.
    Hall, Andrew G.
    Jackson, Graham
    Newell, David R.
    Irving, Julie A. E.
    LEUKEMIA RESEARCH, 2011, 35 (09) : 1233 - 1240
  • [3] Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease
    Leng, Houfu
    Zhang, Hanlin
    Li, Linsen
    Zhang, Shuhao
    Wang, Yanping
    Chavda, Selina J.
    Galas-Filipowicz, Daria
    Lou, Hantao
    Ersek, Adel
    Morris, Emma V.
    Sezgin, Erdinc
    Lee, Yi-Hsuan
    Li, Yunsen
    Lechuga-Vieco, Ana Victoria
    Tian, Mei
    Mi, Jian-Qing
    Yong, Kwee
    Zhong, Qing
    Edwards, Claire M.
    Simon, Anna Katharina
    Horwood, Nicole J.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [4] PRE-CLINICAL APPROACH OF MULTIPLE SIGNAL TRANSDUCTION PATHWAYS INHIBITION IN MULTIPLE MYELOMA
    Ricciardi, M. R.
    Calabrese, E.
    Milella, M.
    Bergamo, P.
    Levi, A.
    De Benedictis, C.
    Foa, R.
    Tafuri, A. Md
    Petrucci, M. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 141 - 141
  • [5] Risedronate prevents bone disease and reduces tumour burden in a syngeneic model of multiple myeloma
    Lawson, MA
    Coulton, L
    Ebetino, FH
    Gallagher, O
    Prideaux, M
    Vanderkerken, K
    Croucher, PI
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (07) : 1160 - 1160
  • [6] Risedronate prevents bone disease and reduces tumour burden in a syngeneic model of multiple myeloma
    Lawson, M. A.
    Coulton, L.
    Ebetino, F. H.
    Gallagher, O.
    Prideaux, M.
    Vanderkerken, K.
    Croucher, P.
    CANCER TREATMENT REVIEWS, 2006, 32 : S35 - S35
  • [7] Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical Model
    Toan Pham
    Sandra Carpinteri
    Shienny Sampurno
    Lloyd Pereira
    Sara Roth
    Vignesh Narasimhan
    Phillip Darcy
    Jayesh Desai
    Alexander G. Heriot
    Robert G. Ramsay
    Journal of Gastrointestinal Surgery, 2019, 23 : 626 - 633
  • [8] Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical Model
    Pham, Toan
    Carpinteri, Sandra
    Sampurno, Shienny
    Pereira, Lloyd
    Roth, Sara
    Narasimhan, Vignesh
    Darcy, Phillip
    Desai, Jayesh
    Heriot, Alexander G.
    Ramsay, Robert G.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (03) : 626 - 633
  • [9] Novel vaccine targeting colonic adenoma: A pre-clinical model
    Pham, Toan D.
    Carpinteri, Sandra
    Sampurno, Shienny
    Pereira, Lloyd
    Roth, Sara
    Narasimhan, Vignesh
    Wilson, Kasmira
    Darcy, Phillip
    Desai, Jayesh
    Heriot, Alexander G.
    Ramsay, Robert G.
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Neoantigen Synthetic Peptide Vaccine for Multiple Myeloma Elicits T Cell Immunity in a Pre-Clinical Model
    Bekri, Selma
    Uduman, Mohamed
    Gruenstein, Diana
    Mei, Anna Huo-Chang
    Tung, Kaity
    Rodney-Sandy, Reunet
    Bogen, Bjarne
    Buell, Jennifer
    Stein, Robert
    Doherty, Kaitlin
    Findeis, Mark
    Morin, Benjamin
    Joshi, Bishnu
    Tanne, Antoine
    Castle, John
    Levey, Daniel
    Cho, Hearn Jay
    BLOOD, 2017, 130
12345